Merck said on Monday it will split its human-health business into two divisions, separating its blockbuster cancer franchise led by Keytruda from its non-oncology medicines. The shake-up comes as the ...
As sport management researchers, we see lots of good intentions but also a disturbing amount of failures and outright fraud. (The Conversation is an independent and nonprofit source of news, analysis ...
